Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2007 Apr 15;109(8):3529-37.
doi: 10.1182/blood-2006-05-021402. Epub 2006 Dec 21.

Natural history and early diagnosis of LAD-1/variant syndrome

Affiliations
Free article
Clinical Trial

Natural history and early diagnosis of LAD-1/variant syndrome

Taco W Kuijpers et al. Blood. .
Free article

Abstract

The syndrome of leukocyte adhesion deficiency (LAD) combined with a severe Glanzmann-type bleeding disorder has been recognized as a separate disease entity. The variability in clinical and cell biological terms has remained largely unclear. We present data on 9 cases from 7 unrelated families, with 3 patients being actively followed for more than 12 years. The disease entity, designated LAD-1/variant syndrome, presents early in life and consists of nonpussing infections from bacterial and fungal origin, as well as a severe bleeding tendency. This is compatible with 2 major blood cell types contributing to the clinical symptoms (ie, granulocytes and platelets). In granulocytes of the patients, we found adhesion and chemotaxis defects, as well as a defect in NADPH oxidase activity triggered by unopsonized zymosan. This last test can be used as a screening test for the syndrome. Many proteins and genes involved in adhesion and signaling, including small GTPases such as Rap1 and Rap2 as well as the major Rap activity-regulating molecules, were normally present. Moreover, Rap1 activation was intact in patients' blood cells. Defining the primary defect awaits genetic linkage analysis, which may be greatly helped by a more precise understanding and awareness of the disease combined with the early identification of affected patients.

PubMed Disclaimer

Comment in

  • LAD III versus LAD I variant.
    Etzioni A, Alon R. Etzioni A, et al. Blood. 2007 Dec 1;110(12):4129; author reply 4129-30. doi: 10.1182/blood-2007-05-089227. Blood. 2007. PMID: 18024798 No abstract available.

Similar articles

Cited by

MeSH terms